Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion of cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to [email protected]) ...

About Purdue Pharma L.P. Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers.

In Harrington v. Purdue Pharma L.P., the Supreme Court held that the Bankruptcy Code does not authorize a bankruptcy court to ...

FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo ...

Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy bankruptcy case says.

Purdue Pharma asked a bankruptcy judge this week to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal that ...

Purdue Pharma Files New Bankruptcy Plan for $7.4 Billion Opioid Settlement By Dietrich Knauth NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday ...

NEW YORK, March 19 (Reuters) - Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after ...